BSXTICKER
Boston Scientific Corp.
Congress has disclosed 37 buys and 53 sells of BSX (Boston Scientific Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
37
Buy
53
Sell
-16
Net
19
Active politicians
Round-trip watch Still on the books
Members who disclosed buying BSX and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $69.17 | $41.98 | -39.3% | underwater |
| Gilbert Cisneros | 2026-08-18 | $50.47 | $41.98 | -16.8% | underwater |
| Rohit Khanna | 2026-08-10 | $50.46 | $41.98 | -16.8% | underwater |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
17.42
▼ cheaper than
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$41.98 ÷ $2.41 = 17.42
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.37
▼ cheaper than
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$41.98 ÷ $17.68 = 2.37
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
11.56
▼ cheaper than
Health (median 16.2)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($60.8B + $0.4B net debt) ÷ $5.3B = $61.3B ÷ $5.3B = 11.56
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
90 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Kevin Hern | House | SELL ◆ insider divergence · strong | Joint · Hern Family Revocable Trust | 2026-09-09 | 6 days | -2.4% | $50K–$100K 0.9% of NW |
97.7 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider divergence · strong | Joint · Hern Family Revocable Trust | 2026-09-04 | 11 days | -8.2% | $50K–$100K 0.9% of NW |
97.5 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider divergence · strong | Child · Gabrielle Ashtyn Hern Trust | 2026-09-03 | 12 days | -6.6% | $1K–$15K 0.1% of NW |
94.0 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider divergence · strong | Child · Kelby Austin Hern Trust | 2026-09-03 | 12 days | -6.6% | $1K–$15K 0.1% of NW |
94.0 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider divergence · strong | Child · Kaden Everett Hern Trust | 2026-09-03 | 12 days | -6.6% | $1K–$15K 0.1% of NW |
94.0 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-08-18 | 17 days | -5.3% | $1K–$15K 0.1% of NW |
33.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2026-08-10 | 22 days | -4.7% | $1K–$15K | 53.7 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-06-05 | 27 days | -7.0% | $1K–$15K 0.1% of NW |
13.9 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider divergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-06-05 | 27 days | -7.0% | $1K–$15K 0.1% of NW |
13.9 | ↗ filing |
| John Boozman | Senate | SELL ◆ insider divergence · strong | Joint | 2026-06-04 | 39 days | -8.6% | $1K–$15K | 99.7 | ↗ eFD |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2026-06-02 | 29 days | -9.7% | $1K–$15K | 31.1 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-05-29 | 7 days | +0.5% | $1K–$15K 0.1% of NW |
13.2 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-05-19 | 17 days | -14.5% | $1K–$15K 0.1% of NW |
11.7 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider convergence · strong | Self · 150 Main Street Trust > Bank of America | 2026-05-11 | 25 days | -9.0% | $1K–$15K 0.1% of NW |
11.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence · strong | Child | 2026-03-30 | 3 days | -0.2% | $15K–$50K | 59.0 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider convergence · strong | Spouse | 2026-03-27 | 10 days | -9.5% | $1K–$15K | 33.3 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider convergence · strong | Self | 2026-03-27 | 116 days | -37.6% | $1K–$15K | 99.7 | ↗ eFD |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2026-02-10 | 24 days | -3.9% | $1K–$15K 0.1% of NW |
0.6 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2026-01-30 | 12 days | -21.4% | $1K–$15K 0.1% of NW |
0.5 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-12-24 | 16 days | +1.6% | $1K–$15K 0.1% of NW |
0.5 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-11-18 | 24 days | -6.7% | $1K–$15K 0.1% of NW |
6.2 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
66.9 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | +0.1% | $1K–$15K 0.1% of NW |
82.7 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | +0.1% | $1K–$15K 0.1% of NW |
82.7 | ↗ filing |
| Kevin Hern | House | SELL ◆ insider convergence | Joint · Hern Family Foundation | 2025-10-28 | 1 days | -0.7% | $15K–$50K 0.4% of NW |
92.3 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-10-17 | 26 days | +4.9% | $1K–$15K 0.1% of NW |
6.3 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
30.3 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-08-04 | 9 days | -4.0% | $1K–$15K 0.1% of NW |
89.5 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-07-31 | 13 days | -2.3% | $1K–$15K 0.1% of NW |
7.5 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-06-26 | 12 days | -2.1% | $1K–$15K 0.1% of NW |
0.8 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-06-11 | 27 days | +3.0% | $1K–$15K 0.1% of NW |
1.0 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-05-13 | 22 days | -0.5% | $1K–$15K 0.1% of NW |
11.7 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-04-28 | 7 days | +2.0% | $1K–$15K 0.1% of NW |
17.3 | ↗ filing |
| Bruce Westerman | House | SELL ◆ insider convergence | Self · Fisher IRA | 2025-04-21 | 7 days | +9.2% | $1K–$15K 0.7% of NW |
48.8 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-03-17 | 18 days | -9.3% | $1K–$15K 0.1% of NW |
13.2 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2025-03-12 | 26 days | -5.1% | $1K–$15K | 31.8 | ↗ filing |
| Bruce Westerman | House | BUY ◆ insider divergence | Self · Fisher IRA | 2025-03-03 | 14 days | -5.7% | $1K–$15K 0.7% of NW |
69.4 | ↗ filing |
| Gilbert Cisneros | House | SELL ◆ insider convergence | Self · 150 Main Street Trust > Bank of America | 2025-02-24 | 8 days | -0.7% | $1K–$15K 0.1% of NW |
27.2 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence · moderate | Spouse · Charles Schwab Brokerage Account 548 | 2024-12-11 | 243 days | +13.5% | $1K–$15K 0.1% of NW |
97.3 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider divergence · moderate | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | +23.4% | $1K–$15K 0.8% of NW |
65.6 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2024-04-24 | 12 days | — | $50K–$100K | 49.5 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2024-04-23 | 13 days | — | $100K–$250K | 60.3 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence · moderate | Spouse | 2024-04-12 | 24 days | — | $15K–$50K | 56.6 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-01-10 | 23 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-12-05 | 30 days | — | $1K–$15K | 75.9 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence | Joint · Northwestern Mutual - Joint | 2023-12-04 | 0 days | — | $1K–$15K | 10.6 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X142 | 2023-09-08 | 28 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X141 | 2023-09-08 | 28 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X141 | 2023-05-31 | 22 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Lois Frankel | House | BUY ◆ insider divergence | Self · Morgan Stanley IRA - X142 | 2023-05-30 | 23 days | — | $1K–$15K 0.3% of NW |
2.6 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X142 | 2023-05-01 | 18 days | — | $1K–$15K 0.3% of NW |
13.4 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence | Joint · Northwestern Mutual - Joint | 2023-04-26 | 6 days | — | $1K–$15K | 33.6 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X141 | 2023-04-19 | 30 days | — | $1K–$15K 0.3% of NW |
25.7 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X141 | 2023-03-29 | 30 days | — | $1K–$15K 0.3% of NW |
28.4 | ↗ filing |
| Michael McCaul | House | SELL OCR ◆ insider convergence | Spouse | 2023-03-27 | 10 days | — | $50K–$100K | 97.5 | ↗ filing |
| John Curtis | House | SELL ◆ insider convergence | Joint · Northwestern Mutual - Joint | 2023-02-23 | 13 days | — | $1K–$15K | 22.3 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse · Neuberger Berman - Traditional IRA | 2022-10-24 | 7 days | — | $1K–$15K | 2.6 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse · Neuberger Berman - Traditional IRA | 2022-10-21 | 7 days | — | $1K–$15K | 5.5 | ↗ filing |
| Alan Lowenthal | House | SELL | Joint · Neuberger Berman - Malumed Lowenthal Rev Trust #2 | 2022-10-21 | 7 days | — | $1K–$15K | 5.5 | ↗ filing |
| Lois Frankel | House | BUY | Self · Morgan Stanley IRA - X141 | 2022-09-28 | 23 days | — | $1K–$15K 0.3% of NW |
8.6 | ↗ filing |
| Robert Wittman | House | SELL | Self | 2021-12-16 | 4 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2021-08-06 | 5 days | — | $1K–$15K | 6.8 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2021-08-03 | 7 days | — | $1K–$15K | 8.6 | ↗ filing |
| Kevin Hern | House | BUY | Joint | 2021-07-01 | 1 days | — | $100K–$250K 2.1% of NW |
99.2 | ↗ filing |
| John Curtis | House | BUY | Self | 2021-06-22 | 9 days | — | $1K–$15K | 52.4 | ↗ filing |
| Kevin Hern | House | BUY | Child | 2021-05-20 | 1 days | — | $1K–$15K 0.1% of NW |
98.8 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 75.9 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2021-02-02 | 7 days | — | $1K–$15K | 10.6 | ↗ filing |
| Alan Lowenthal | House | BUY | Joint | 2021-02-01 | 7 days | — | $1K–$15K | 15.7 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2020-12-18 | 20 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2020-10-21 | 0 days | — | $1K–$15K 0.3% of NW |
19.6 | ↗ filing |
| Robert Wittman | House | BUY | Self | 2020-10-02 | 4 days | — | $1K–$15K 0.2% of NW |
86.8 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-08-10 | 31 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-04-14 | 22 days | — | $1K–$15K <0.1% of NW |
26.5 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-04-09 | 27 days | — | $1K–$15K <0.1% of NW |
31.8 | ↗ filing |
| John Curtis | House | BUY | Self | 2020-03-27 | 0 days | — | $1K–$15K | 93.1 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2020-03-26 | 0 days | — | $1K–$15K 0.3% of NW |
33.6 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2020-03-19 | 5 days | — | $1K–$15K | 31.8 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-03-18 | 28 days | — | $1K–$15K 0.1% of NW |
93.1 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2020-03-18 | 0 days | — | $1K–$15K 0.3% of NW |
50.5 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2020-03-11 | 5 days | — | $1K–$15K | 52.4 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-02-27 | 8 days | — | $1K–$15K <0.1% of NW |
59.5 | ↗ filing |
| Mo Brooks | House | SELL | Joint | 2020-02-05 | 0 days | — | $1K–$15K | 86.8 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2019-07-30 | 0 days | — | $1K–$15K 0.3% of NW |
40.4 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2019-04-25 | 6 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2017-12-14 | 6 days | — | $15K–$50K | 90.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2017-04-20 | 475 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2017-02-01 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2016-09-12 | 3 days | — | $1K–$15K | 40.4 | ↗ filing |
| Michael Conaway | House | BUY | Spouse | 2015-03-18 | 5 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in BSX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
37
Congress trades with insider convergence
19
…with insider divergence
150
Insider open-market trades
Of the congressional trades in BSX, 37 coincided with corporate insiders moving the same way within 60 days, and 19 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-08-25 | Morano Susan E | Director | BUY | $100K | ↗ EDGAR |
| 2026-08-05 | Habiger David C | Director | BUY | $100K | ↗ EDGAR |
| 2026-08-04 | Habiger David C | Director | BUY | $7K | ↗ EDGAR |
| 2026-08-03 | Mahoney Michael F | C-suite | BUY | $9.0M | ↗ EDGAR |
| 2026-08-03 | Habiger David C | Director | BUY | $50K | ↗ EDGAR |
| 2026-07-31 | LUDWIG EDWARD J | Director | BUY | $227K | ↗ EDGAR |
| 2026-05-20 | Habiger David C | Director | BUY | $126K | ↗ EDGAR |
| 2026-05-20 | LUDWIG EDWARD J | Director | BUY | $203K | ↗ EDGAR |
| 2026-05-20 | Pegus Cheryl | Director | BUY | $100K | ↗ EDGAR |
| 2026-05-19 | Habiger David C | Director | BUY | $125K | ↗ EDGAR |
| 2026-02-02 | Mahoney Michael F | C-suite | SELL 10b5-1 | $113K | ↗ EDGAR |
| 2026-02-02 | Mahoney Michael F | C-suite | SELL 10b5-1 | $14.9M | ↗ EDGAR |
| 2025-12-01 | Butcher Arthur C | Other | SELL 10b5-1 | $1.8M | ↗ EDGAR |
| 2025-11-06 | Zane Ellen M | Director | SELL 10b5-1 | $1.3M | ↗ EDGAR |
| 2025-11-03 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $363K | ↗ EDGAR |
| 2025-11-03 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2025-11-03 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $2.9M | ↗ EDGAR |
| 2025-10-28 | Zane Ellen M | Director | SELL 10b5-1 | $297K | ↗ EDGAR |
| 2025-10-27 | Zane Ellen M | Director | SELL 10b5-1 | $1.0M | ↗ EDGAR |
| 2025-10-01 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $815K | ↗ EDGAR |
| 2025-10-01 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $4.1M | ↗ EDGAR |
| 2025-09-02 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $2.3M | ↗ EDGAR |
| 2025-09-02 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $3.0M | ↗ EDGAR |
| 2025-08-01 | Butcher Arthur C | Other | SELL 10b5-1 | $1.8M | ↗ EDGAR |
| 2025-08-01 | Fitzgerald Joseph Michael | Other | SELL 10b5-1 | $5.2M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-09-09 | Kevin Hern | SELL | $50K–$100K |
| Congress | 2026-09-04 | Kevin Hern | SELL | $50K–$100K |
| Congress | 2026-09-03 | Kevin Hern | SELL | $1K–$15K |
| Congress | 2026-09-03 | Kevin Hern | SELL | $1K–$15K |
| Congress | 2026-09-03 | Kevin Hern | SELL | $1K–$15K |
| ◆ insider | 2026-08-25 | Morano Susan E Director | BUY | $100K |
| Congress | 2026-08-18 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-08-10 | Rohit Khanna | BUY | $1K–$15K |
| ◆ insider | 2026-08-05 | Habiger David C Director | BUY | $100K |
| ◆ insider | 2026-08-04 | Habiger David C Director | BUY | $7K |
| ◆ insider | 2026-08-03 | Mahoney Michael F C-suite | BUY | $9.0M |
| ◆ insider | 2026-08-03 | Habiger David C Director | BUY | $50K |
| ◆ insider | 2026-07-31 | LUDWIG EDWARD J Director | BUY | $227K |
| Congress | 2026-06-05 | Gilbert Cisneros | BUY | $1K–$15K |
| Congress | 2026-06-05 | Gilbert Cisneros | SELL | $1K–$15K |
| Congress | 2026-06-04 | John Boozman | SELL | $1K–$15K |
| Congress | 2026-06-02 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-05-29 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2026-05-20 | Habiger David C Director | BUY | $126K |
| ◆ insider | 2026-05-20 | LUDWIG EDWARD J Director | BUY | $203K |
| ◆ insider | 2026-05-20 | Pegus Cheryl Director | BUY | $100K |
| Congress | 2026-05-19 | Gilbert Cisneros | BUY | $1K–$15K |
| ◆ insider | 2026-05-19 | Habiger David C Director | BUY | $125K |
| Congress | 2026-05-11 | Gilbert Cisneros | BUY | $1K–$15K |
FAQ Common questions
How much has Congress traded BSX?
37 disclosed buys and 53 sells of BSX (Boston Scientific Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade BSX?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.